KR20240159636A - 수성 조성물 - Google Patents

수성 조성물 Download PDF

Info

Publication number
KR20240159636A
KR20240159636A KR1020247035255A KR20247035255A KR20240159636A KR 20240159636 A KR20240159636 A KR 20240159636A KR 1020247035255 A KR1020247035255 A KR 1020247035255A KR 20247035255 A KR20247035255 A KR 20247035255A KR 20240159636 A KR20240159636 A KR 20240159636A
Authority
KR
South Korea
Prior art keywords
aqueous composition
sodium
salts
component
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247035255A
Other languages
English (en)
Korean (ko)
Inventor
리카 오리타니
지세 기타니
아키노리 니시모토
Original Assignee
가부시키가이샤 쓰보타 라보
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 쓰보타 라보 filed Critical 가부시키가이샤 쓰보타 라보
Publication of KR20240159636A publication Critical patent/KR20240159636A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1020247035255A 2022-03-25 2023-03-24 수성 조성물 Pending KR20240159636A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2022-050275 2022-03-25
JP2022050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
KR20240159636A true KR20240159636A (ko) 2024-11-05

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247035255A Pending KR20240159636A (ko) 2022-03-25 2023-03-24 수성 조성물

Country Status (14)

Country Link
US (1) US20250213510A1 (cg-RX-API-DMAC7.html)
EP (1) EP4483867A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023182480A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240159636A (cg-RX-API-DMAC7.html)
CN (1) CN118973561A (cg-RX-API-DMAC7.html)
AU (1) AU2023240729A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254664A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002831A1 (cg-RX-API-DMAC7.html)
IL (1) IL315871A (cg-RX-API-DMAC7.html)
MA (1) MA67594B1 (cg-RX-API-DMAC7.html)
MX (1) MX2024011634A (cg-RX-API-DMAC7.html)
PE (1) PE20250746A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400133A (cg-RX-API-DMAC7.html)
WO (1) WO2023182480A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026130361A1 (zh) * 2024-12-17 2026-06-25 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018164113A1 (ja) 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2020129965A1 (ja) 2018-12-18 2020-06-25 参天製薬株式会社 4-フェニル酪酸を含有する老視の治療または予防剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
EP2698155A1 (en) * 2012-08-16 2014-02-19 Lunamed AG Pharmaceutical unit dosage form comprising 4-phenylbutyric acid
EP3603642B1 (en) * 2017-03-27 2024-01-10 Alcon Inc. Pharmaceutical preparation
CN111024960B (zh) * 2019-12-27 2023-02-17 广州阳普医疗科技股份有限公司 用于高血压血样检测的添加剂、试剂盒和应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018164113A1 (ja) 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2020129965A1 (ja) 2018-12-18 2020-06-25 参天製薬株式会社 4-フェニル酪酸を含有する老視の治療または予防剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
부페닐(등록상표)정 500mg 부페닐(등록상표) 과립 94% 첨부 문서

Also Published As

Publication number Publication date
EP4483867A1 (en) 2025-01-01
WO2023182480A1 (ja) 2023-09-28
US20250213510A1 (en) 2025-07-03
CN118973561A (zh) 2024-11-15
MX2024011634A (es) 2024-09-30
IL315871A (en) 2024-11-01
MA67594B1 (fr) 2026-01-30
CL2024002831A1 (es) 2025-01-24
MA67594A1 (fr) 2025-07-31
EP4483867A4 (en) 2026-06-24
TW202400133A (zh) 2024-01-01
JPWO2023182480A1 (cg-RX-API-DMAC7.html) 2023-09-28
AU2023240729A1 (en) 2024-10-03
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13

Similar Documents

Publication Publication Date Title
US20250262149A1 (en) Aqueous ophthalmic solutions of phentolamine and medical uses thereof
JP7624538B2 (ja) 眼科組成物
KR20180052130A (ko) 리포산 콜린 에스테르 조성물, 및 생체적합성 안과용 제형의 생성 방법
JP2014214085A (ja) オロパタジン含有水性組成物
US20230172969A1 (en) Ophthalmic Composition
JP2022157707A (ja) 眼科組成物
JP5532609B2 (ja) 眼科用組成物及び刺激緩和剤
JP2025142313A (ja) ソフトコンタクトレンズ用眼科組成物
JP2014088371A (ja) プラノプロフェン含有水性組成物
AU2023240729A1 (en) Aqueous composition
KR20080041621A (ko) 잔탄 검 및 테르페노이드를 포함하는 점안제
JPWO2018225729A1 (ja) ソフトコンタクトレンズ用眼科用組成物及びビタミンa分離抑制方法
JP5753958B2 (ja) 澄明な水性液剤
HK40113837A (en) Aqueous composition
JP7304168B2 (ja) 点眼剤
JP5019923B2 (ja) プラノプロフェン含有医薬組成物
WO2024203727A1 (ja) 水性組成物
CA3305276A1 (en) Aqueous composition
US20140296348A1 (en) Ophthalmological aqueous composition
TW202519197A (zh) 水性組成物
EP4534081A1 (en) Ophthalmic composition
EP4534082A1 (en) Ophthalmic composition
JP2012224629A (ja) ペミロラストを含有する安定な水性組成物
WO2021107033A1 (ja) 医薬組成物
JP2018111732A (ja) オロパタジン含有水性組成物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241023

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application